Compendium of Cancer Genome Aberrations

STBT5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 293: Line 293:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|9/22/2025
|
|Katie Schieffer
|
|9/22/2025
|
|
|-
|-
Line 312: Line 312:
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 378: Line 378:
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 420: Line 420:
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 453: Line 453:
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Disease
|Kate Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|
|Disease
|
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|
|
|
|
Line 539: Line 539:
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 658: Line 658:
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 669: Line 669:
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 680: Line 680:
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|
|
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 713: Line 713:
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 777: Line 777:
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 786: Line 797:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|Disease
|
|
Line 797: Line 808:
|
|
|-
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 907: Line 907:
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 1,092: Line 1,092:
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 1,112: Line 1,112:
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|
|
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 1,189: Line 1,189:
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|921/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 1,522: Line 1,522:
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
<br />
|
|
|
|
Line 1,531: Line 1,543:
|
|
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,542: Line 1,565:
|
|
|-
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,553: Line 1,587:
|
|
|-
|-
|[[STBT5:Enchondroma|Enchondroma]]
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|Disease
|
|
Line 1,564: Line 1,598:
|
|
|-
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|Disease
|
|
Line 1,575: Line 1,609:
|
|
|-
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|Disease
|
|
Line 1,586: Line 1,620:
|
|
|-
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,608: Line 1,662:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,619: Line 1,673:
|
|
|-
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,630: Line 1,684:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,641: Line 1,695:
|
|
|-
|-
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|
|
|
|
|
|
Line 1,661: Line 1,706:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,672: Line 1,717:
|
|
|-
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|[[STBT5:Osteoma|Osteoma]]
|Disease
|Disease
|
|
Line 1,683: Line 1,728:
|
|
|-
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|Disease
|
|
Line 1,694: Line 1,739:
|
|
|-
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|Disease
|
|
Line 1,705: Line 1,750:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|Disease
|
|
Line 1,716: Line 1,761:
|
|
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|-
|Disease
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|
|
|
|
|
|
Line 1,727: Line 1,781:
|
|
|-
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,738: Line 1,792:
|
|
|-
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,749: Line 1,803:
|
|
|-
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|Disease
|
|
Line 1,760: Line 1,814:
|
|
|-
|-
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Disease
|
|
Line 1,780: Line 1,825:
|
|
|-
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|Disease
|
|
Line 1,791: Line 1,836:
|
|
|-
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,802: Line 1,847:
|
|
|-
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 1,813: Line 1,858:
|
|
|-
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|Disease
|
|
Line 1,824: Line 1,869:
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|Disease
|
|
Line 1,835: Line 1,880:
|
|
|-
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,846: Line 1,900:
|
|
|-
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|Disease
|
|
Line 1,857: Line 1,911:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|Disease
|
|
Line 1,868: Line 1,922:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|Disease
|
|
Line 1,879: Line 1,933:
|
|
|-
|-
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,899: Line 1,944:
|
|
|-
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|Disease
|
|
Line 1,910: Line 1,955:
|
|
|-
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Line 1,921: Line 1,966:
|
|
|-
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|Disease
|
|
Line 1,932: Line 1,977:
|
|
|-
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,943: Line 1,999:
|
|
|-
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|Disease
|
|
Line 1,954: Line 2,019:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,965: Line 2,041:
|
|
|-
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|Disease
|
|
Line 1,976: Line 2,052:
|
|
|-
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,987: Line 2,074:
|
|
|-
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|Disease
|
|
Line 1,998: Line 2,085:
|
|
|-
|-
|-
|[[STBT5:Bone_metastases|Bone metastases]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
Line 2,097: Line 2,098:
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|PENDING
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/STBT5:Volunteer_Assignments_and_Opportunities"